Newest study demonstrated that TSP-1 together with two other biomarkers: brain angiogenesis inhibitor 1 and E-Cadherin had higher sensitivity and specificity than classical biomarkers in early diagnosis of lung cancer [29]. This evidence concerns the gene THBS1 and lung cancer.